Posts

Showing posts from January, 2026

Implications of US Withdrawal from World Bodies – Asrar Qureshi’s Blog Post #1214

Image
Implications of US Withdrawal from World Bodies – Asrar Qureshi’s Blog Post #1214 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1214 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Safi Erneste Preamble This blog post is based on an article written by Lydia Gichuki for DevelopmentAid Digest.. Link at the end. When a Superpower Steps Back: How the U.S. Exit from 66 Global Bodies Is Rewriting the World System In early January 2026, the United States government made a move with seismic implications for international cooperation: President Donald J. Trump signed a presidential memorandum directing the withdrawal of the U.S. from 66 international organizations, a sweeping disengagement that spans United Nations bodies and non-UN multilateral institutions. This move marks far more than a policy shift. It heralds a ...

Team Size – Gallup Report – Asrar Qureshi’s Blog Post #1213

Image
Team Size – Gallup Report – Asrar Qureshi’s Blog Post #1213 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1213 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Matheus Bertelli Credit: Yusuf Çelik Preamble This blog post is based on a recent Gallup® report. Link at the end. Why Team Size Matters: Insights from Gallup on Optimal Span of Control for Managers In today’s rapidly evolving workplace, organizations are constantly asking: How many people should report to a manager? While the question seems straightforward, the answer is far from simple. According to new Gallup research, the “span of control” – the number of direct reports a manager oversees – has significant implications for organizational performance, employee engagement, leadership effectiveness, and overall workplace health. Gallup’s analysis revea...

Top Risks for 2026 Part 3 – Eurasia Group Report – Asrar Qureshi’s Blog Post #1212

Image
Top Risks for 2026 Part 3 – Eurasia Group Report – Asrar Qureshi’s Blog Post #1212 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1212 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Afitab Credit: Ahmed Aziz Credit: Tima Miroshnichenko Preamble This 3-part blog post is based on a Eurasia Group report titled ‘Top Risks for 2026’. Link at the end. About Eurasia Group. [Quote]. Today's geopolitical environment is increasingly complex, with risks coming at an accelerated pace as the world order undergoes significant change.  It has never been more important for business decision-makers and investors to incorporate political risk into their strategies to spot the opportunities and manage the risks that politics creates—and to lead their organizations through turbulent times. Eurasia Group's advisory and consu...

Top Risks for 2026 Part 2 – Eurasia Group Report – Asrar Qureshi’s Blog Post #1211

Image
Top Risks for 2026 Part 2 – Eurasia Group Report – Asrar Qureshi’s Blog Post #1211 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1211 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Kelly Credit: Wolfgang Weiser Preamble This 3-part blog post is based on a Eurasia Group report titled ‘Top Risks for 2026’. Link at the end. About Eurasia Group. [Quote]. Today's geopolitical environment is increasingly complex, with risks coming at an accelerated pace as the world order undergoes significant change.  It has never been more important for business decision-makers and investors to incorporate political risk into their strategies to spot the opportunities and manage the risks that politics creates—and to lead their organizations through turbulent times. Eurasia Group's advisory and consulting business is built ...

Top Risks for 2026 - Part 1 – Eurasia Group Report – Asrar Qureshi’s Blog Post #1210

Image
Top Risks for 2026 - Part 1 – Eurasia Group Report – Asrar Qureshi’s Blog Post #1210 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1210 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Google Images Credit: Google Images Preamble This 3-part blog post is based on a Eurasia Group report titled ‘Top Risks for 2026’. Link at the end. About Eurasia Group. [Quote]. Today's geopolitical environment is increasingly complex, with risks coming at an accelerated pace as the world order undergoes significant change.  It has never been more important for business decision-makers and investors to incorporate political risk into their strategies to spot the opportunities and manage the risks that politics creates—and to lead their organizations through turbulent times. Eurasia Group's advisory and consulting business i...

Thriving Organizations 2 – Asrar Qureshi’s Blog Post #1209

Image
Thriving Organizations 2 – Asrar Qureshi’s Blog Post #1209 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1209 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Kindel Media Credit: Manuel Guillen Vega Credit: Pavel Danilyuk Preamble This 2-part blog post is based on a McKinsey Health Institute report ‘Thriving Workplaces: How Employees Can Improve Productivity and Change Lives’. Link at the end. The report makes the case that employers must shift from viewing health programs as perks to embedding holistic employee health as a core strategic imperative that boosts productivity, reduces costs, and transforms lives. Part II: How Employers Can Build Thriving Workplaces That Boost Productivity and Change Lives Introduction: The ‘How’ Behind the Promise In Part I we explored why thriving workplaces are essential, bot...

Thriving Organizations 1 – Asrar Qureshi’s Blog Post #1208

Image
Thriving Organizations 1 – Asrar Qureshi’s Blog Post #1208 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1208 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Ketut Subiyanto Credit: Matheus Bertelli Preamble This 2-part blog post is based on a McKinsey Health Institute report ‘Thriving Workplaces: How Employees Can Improve Productivity and Change Lives’. Link at the end. The report makes the case that employers must shift from viewing health programs as perks to embedding holistic employee health as a core strategic imperative that boosts productivity, reduces costs, and transforms lives. Part I: Why the Future of Work Depends on Thriving Workplaces For decades, businesses focused narrowly on efficiency, cost cutting, and output, often sidelining the human experience of work. But in the 2020s, that model has ...

Active Pharmaceutical Ingredients Manufacturing in Pakistan – Asrar Qureshi’s Blog Post #1207

Image
Active Pharmaceutical Ingredients Manufacturing in Pakistan – Asrar Qureshi’s Blog Post #1207 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1207 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Preamble For readers who are not from pharma industry, here is a brief background. Pharmaceutical products, commonly known as ‘Medicines’ or ‘Drugs’ are formulated by combining two main categories of ingredients: Active Pharmaceutical Ingredients - APIs’ and ‘Inactive Substances or Excipients’. Tablets, capsules, dry syrups and liquid syrups are all manufactured like this. Injections also have API(s) but may or may not have excipients. Pakistan pharma market is divided into three main segments: Retail sales, Institutional Sales, and Trade sales. According to the US company IQVIA, which collects and publishes pharma industry dat...

Gaps in Women’s Consumer Health Needs – Pakistan Perspective – Asrar Qureshi’s Blog Post #1206

Image
Gaps in Women’s Consumer Health Needs – Pakistan Perspective – Asrar Qureshi’s Blog Post #1206 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1206 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Muneeb Malhotra Credit: Muneed Malhotra Credit: Karola G Credit: Tima Miroshnichenko Preamble This 2-part blog post synthesizes the key insights from the Boston Consulting Group (BCG) article “Closing the Gap in Women’s Consumer Health Needs”, why women’s health needs are widely underserved in the consumer market, how this impacts both women and businesses, and what companies should do to address this unmet opportunity. Link at the end.  Women’s Health Needs in Pakistan – The Unmet Reality In Pakistan, women’s health challenges are compounded by cultural norms, limited access to healthcare, and underinvestment in ...